Total Payments
$11,614
2024 Payments
$1,494
Companies
41
Transactions
494
Medicare Patients
281
Medicare Billing
$23,061

Payment Breakdown by Category

Food & Beverage$11,529 (99.3%)
Education$84.99 (0.7%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $11,529 493 99.3%
Education $84.99 1 0.7%

Top Paying Companies

Company Total Records Latest Year
ABBVIE INC. $1,715 95 $0 (2024)
Novo Nordisk Inc $1,289 54 $0 (2024)
Boehringer Ingelheim Pharmaceuticals, Inc. $970.97 17 $0 (2023)
Salix Pharmaceuticals, a division of Bausch Health US, LLC $838.12 59 $0 (2024)
GlaxoSmithKline, LLC. $721.15 37 $0 (2024)
Amgen Inc. $568.96 22 $0 (2024)
AstraZeneca Pharmaceuticals LP $490.37 28 $0 (2024)
Kowa Pharmaceuticals America, Inc. $461.64 28 $0 (2024)
Astellas Pharma US Inc $368.65 13 $0 (2024)
Esperion Therapeutics, Inc. $339.14 15 $0 (2024)

Payment History by Year

Year Amount Transactions Top Company
2024 $1,494 71 ABBVIE INC. ($273.16)
2023 $1,708 87 Axsome Therapeutics, Inc. ($267.97)
2022 $2,055 98 ABBVIE INC. ($518.51)
2021 $1,789 102 Salix Pharmaceuticals, a division of Bausch Health US, LLC ($410.42)
2020 $675.16 32 AbbVie Inc. ($172.27)
2019 $925.45 26 Horizon Therapeutics plc ($168.07)
2018 $1,632 35 Boehringer Ingelheim Pharmaceuticals, Inc. ($514.13)
2017 $1,335 43 Horizon Pharma plc ($334.69)

All Payment Transactions

494 individual payment records from CMS Open Payments — Page 16 of 20

Date Company Product Nature Form Amount Type
09/22/2020 GlaxoSmithKline, LLC. TRELEGY ELLIPTA (Drug) Food and Beverage In-kind items and services $16.19 General
Category: RESPIRATORY
09/17/2020 Allergan, Inc. UBRELVY (Drug) Food and Beverage In-kind items and services $11.25 General
Category: NEUROSCIENCE
09/08/2020 Horizon Therapeutics plc DUEXIS (Drug) Food and Beverage In-kind items and services $19.43 General
Category: DUEXIS
09/01/2020 E.R. Squibb & Sons, L.L.C. ELIQUIS (Drug) Food and Beverage Cash or cash equivalent $16.80 General
Category: Cardiovascular
08/11/2020 SANOFI-AVENTIS U.S. LLC SOLIQUA 100/33 (Biological) Food and Beverage In-kind items and services $16.76 General
Category: Endocrinology
08/10/2020 GlaxoSmithKline, LLC. TRELEGY ELLIPTA (Drug) Food and Beverage In-kind items and services $16.67 General
Category: RESPIRATORY
07/19/2020 AbbVie Inc. CREON (Drug) Food and Beverage In-kind items and services $13.81 General
Category: ENDOCRINOLOGY
07/01/2020 Novo Nordisk Inc Ozempic (Drug), RYBELSUS Food and Beverage In-kind items and services $15.02 General
Category: Diabetes
06/25/2020 Kowa Pharmaceuticals America, Inc. Livalo (Drug) Food and Beverage Cash or cash equivalent $16.49 General
Category: Cardiovascular
03/11/2020 E.R. Squibb & Sons, L.L.C. ELIQUIS (Drug) Food and Beverage Cash or cash equivalent $11.87 General
Category: Cardiovascular
02/26/2020 SANOFI-AVENTIS U.S. LLC SOLIQUA 100/33 (Biological) Food and Beverage In-kind items and services $21.68 General
Category: Endocrinology
02/20/2020 Takeda Pharmaceuticals U.S.A., Inc. MOTEGRITY (Drug) Food and Beverage In-kind items and services $23.21 General
Category: INTERNAL MEDICINE
01/30/2020 AbbVie Inc. RINVOQ (Drug) Food and Beverage In-kind items and services $123.81 General
Category: IMMUNOLOGY
01/22/2020 PFIZER INC. COLOGUARD (Device) Food and Beverage In-kind items and services $16.25 General
Category: GASTROINTESTINAL
01/21/2020 E.R. Squibb & Sons, L.L.C. ELIQUIS (Drug) Food and Beverage Cash or cash equivalent $16.58 General
Category: Cardiovascular
12/19/2019 AstraZeneca Pharmaceuticals LP LOKELMA (Drug) Food and Beverage In-kind items and services $13.28 General
Category: Cardiovascular and Metabolism
12/05/2019 Kowa Pharmaceuticals America, Inc. Livalo (Drug), Bystolic Food and Beverage Cash or cash equivalent $13.56 General
Category: Cardiovascular
11/27/2019 Kowa Pharmaceuticals America, Inc. Livalo (Drug), Bystolic Food and Beverage Cash or cash equivalent $14.99 General
Category: Cardiovascular
11/24/2019 Horizon Therapeutics plc PENNSAID (Drug) Food and Beverage In-kind items and services $21.00 General
Category: PENNSAID
11/22/2019 Boehringer Ingelheim Pharmaceuticals, Inc. JARDIANCE (Drug) Food and Beverage In-kind items and services $114.21 General
Category: DIABETES
11/19/2019 PFIZER INC. COLOGUARD (Device) Food and Beverage In-kind items and services $15.48 General
Category: GASTROINTESTINAL
10/10/2019 Lilly USA, LLC TRULICITY (Drug) Food and Beverage In-kind items and services $18.18 General
Category: Diabetes
10/09/2019 Amgen Inc. Aimovig (Biological), Repatha Food and Beverage In-kind items and services $3.30 General
Category: Neuroscience
09/12/2019 Amgen Inc. Aimovig (Biological), Repatha Food and Beverage In-kind items and services $16.25 General
Category: Neuroscience
07/31/2019 AbbVie, Inc. Creon (Drug) Food and Beverage In-kind items and services $15.91 General
Category: Endocrinology

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 1 15 24 $3,600 $1,377
2022 3 62 78 $10,800 $5,347
2021 4 100 132 $15,500 $9,754
2020 4 104 132 $12,540 $6,583
Total Patients
281
Total Services
366
Medicare Billing
$23,061
Procedure Codes
12

All Medicare Procedures & Services

12 procedure records from CMS Medicare Utilization

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2023 15 24 $3,600 $1,377 38.3%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2022 29 45 $6,750 $2,503 37.1%
G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit Office 2022 16 16 $3,200 $2,469 77.2%
G0444 Annual depression screening, 15 minutes Office 2022 17 17 $850.00 $373.94 44.0%
99213 Established patient outpatient visit, total time 20-29 minutes Office 2021 38 66 $9,600 $4,845 50.5%
G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit Office 2021 25 25 $3,850 $3,822 99.3%
G0447 Face-to-face behavioral counseling for obesity, 15 minutes Office 2021 14 18 $900.00 $571.14 63.5%
G0444 Annual depression screening, 15 minutes Office 2021 23 23 $1,150 $515.66 44.8%
99213 Established patient office or other outpatient visit, typically 15 minutes Office 2020 36 54 $6,750 $3,033 44.9%
G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit Office 2020 17 17 $2,550 $2,296 90.0%
G0444 Annual depression screening, 15 minutes Office 2020 36 42 $2,100 $784.74 37.4%
99212 Established patient office or other outpatient visit, typically 10 minutes Office 2020 15 19 $1,140 $469.48 41.2%

About Dr. Carmen Familia, MD

Dr. Carmen Familia, MD is a Student in an Organized Health Care Education/Training Program healthcare provider based in Bronx, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/17/2010. The National Provider Identifier (NPI) number assigned to this provider is 1770807992.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Carmen Familia, MD has received a total of $11,614 in payments from pharmaceutical and medical device companies, with $1,494 received in 2024. These payments were reported across 494 transactions from 41 companies. The most common payment nature is "Food and Beverage" ($11,529).

As a Medicare-enrolled provider, Familia has provided services to 281 Medicare beneficiaries, totaling 366 services with total Medicare billing of $23,061. Data is available for 4 years (2020–2023), covering 12 distinct procedure/service records.

Practice Information

Products in Payments

  • JARDIANCE (Drug) $907.09
  • UBRELVY (Drug) $726.24
  • Ozempic (Drug) $599.69
  • XIFAXAN (Drug) $531.27
  • RAYOS (Drug) $402.81
  • Livalo (Drug) $393.51
  • NEXLETOL (Drug) $339.14
  • Trulance (Drug) $334.08
  • Rybelsus (Drug) $331.73
  • TRULANCE (Drug) $306.85
  • LINZESS (Drug) $304.39
  • QULIPTA (Drug) $289.74
  • FARXIGA (Drug) $275.37
  • ELIQUIS (Drug) $268.45
  • Auvelity (Drug) $267.97
  • CREON (Drug) $261.41
  • Veozah (Drug) $215.74
  • NUCALA (Biological) $215.70
  • Otezla (Drug) $204.03
  • ZENPEP (Drug) $185.63

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Student in an Organized Health Care Education/Training Program Doctors in Bronx